The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Theralase Technologies Inc

Venture: TLT
Delayed quote

$0.27

Today's change0.00 0.00%
Updated at previous session's close. Delayed by at least 15 minutes.
 

Theralase Technologies Inc

Venture: TLT
Delayed quote

$0.27

Today's change0.00 0.00%
Updated January 1 -- EDT. Delayed by at least 15 minutes.

Theralase Technologies Inc closed at $0.27.

Over the last five days, shares have lost 7.02% and are down 53.51% for the last year to date. This security has underperformed the S&P TSX by 8.78% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.05
Updated at previous session's close. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense1111
Selling / general / administrative1110
Research & development1010
Depreciation / amortization--------
Interest expense (income), net operating0000
Unusual expense (income)--------
Other operating expenses, total000--
Operating income-1-1-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-1-10
Income after tax-1-1-10
Income tax, total0000
Net income-1-1-10
Total adjustments to net income--------
Net income before extra. items-1-1-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-10
Inc. avail. to common incl. extra. items-1-1-10
Diluted net income-1-1-10
Dilution adjustment----0--
Diluted weighted average shares81956859
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.01-0.02-0.01
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.01-0.01-0.02-0.01